Cite

HARVARD Citation

    Al-Hillawi, L. et al. (n.d.). P3 Ustekinumab for the treatment of moderate to severe ulcerative colitis: a multicentre UK cohort study. Gut. pp. A36-A37. [Online]. 
  
Back to record